Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran.
Arai
M
M
D000368:Aged; D000369:Aged, 80 and over; D000928:Antidepressive Agents / Q000009:adverse effects*; D003521:Cyclopropanes / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy; D005260:Female; D020233:Gait Disorders, Neurologic / Q000139:chemically induced; D006801:Humans; D000078764:Milnacipran; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis; D020127:Recovery of Function; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D014202:Tremor / Q000139:chemically induced
D000928:Antidepressive Agents; D003521:Cyclopropanes; D000078764:Milnacipran; D017367:Selective Serotonin Reuptake Inhibitors